findmyKOL
Clinical trialNCT04090697TerminatedPhase 1/PHASE2Interventional

Use of Oxandrolone to Promote Growth in Infants With HLHS

SponsorCarelon ResearchEnrollment34Congenital Heart DiseaseHypoplastic Left Heart
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • the Hospital for Sick Children

    Toronto, Ontario, Canada

United States
  • Children'S Hospital of Atlanta

    Atlanta, Georgia, United States

  • Boston Children'S Hospital

    Boston, Massachusetts, United States

  • University of Michigan Health System, Ann Arbor

    Ann Arbor, Michigan, United States

  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Cook Children'S Medical Center

    Fort Worth, Texas, United States

  • Texas Children'S Hospital

    Houston, Texas, United States

  • Primary Children'S Medical Center

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Dec 2019
Primary completion
19 Sept 2023
Completion
19 Sept 2023
Last update posted
23 May 2024
Registered enrollment
34
Registry id
NCT04090697

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.